Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Hanahan

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Cancer Cell|March 24, 2012
Accessories to the crime: functions of cells recruited to the tumor microenvironmentDouglas Hanahan, Lisa M Coussens
Cell|March 8, 2011
Hallmarks of cancer: the next generationDouglas Hanahan, Robert A Weinberg
Plos One|September 1, 2010
Loss of p19(Arf) facilitates the angiogenic switch and tumor initiation in a multi-stage cancer model via p53-dependent and independent mechanismsDanielle B Ulanet, Douglas Hanahan
Molecular Oncology|February 25, 2012
The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilitiesMichele De Palma, Douglas Hanahan
Nature Cancer|June 25, 2024
Milestones in tumor vascularization and its therapeutic targetingMichele De Palma, Douglas Hanahan
Plos Genetics|September 24, 2010
Genetic deletion of the desmosomal component desmoplakin promotes tumor microinvasion in a mouse model of pancreatic neuroendocrine carcinogenesisMatthew G H Chun, Douglas Hanahan
Cancer Research|June 5, 2003
Fourteenth Annual Pezcoller Symposium: the novel dichotomy of immune interactions with tumorsDouglas Hanahan, Antonio Lanzavecchia, Enrico Mihich
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2006
Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesisHiroaki Nozawa, Christopher Chiu, Douglas Hanahan
Cancer Cell|September 29, 2015
Dual Targeting of the Autophagic Regulatory Circuitry in Gliomas with Repurposed Drugs Elicits Cell-Lethal Autophagy and Therapeutic BenefitKsenya Shchors, Aristea Massaras, Douglas Hanahan
The Journal of Clinical Investigation|September 3, 2004
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesisEnrico Giraudo, Masahiro Inoue, Douglas Hanahan
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Cancer Cell|March 24, 2012
Accessories to the crime: functions of cells recruited to the tumor microenvironmentDouglas Hanahan, Lisa M Coussens
Cell|March 8, 2011
Hallmarks of cancer: the next generationDouglas Hanahan, Robert A Weinberg
Plos One|September 1, 2010
Loss of p19(Arf) facilitates the angiogenic switch and tumor initiation in a multi-stage cancer model via p53-dependent and independent mechanismsDanielle B Ulanet, Douglas Hanahan
Molecular Oncology|February 25, 2012
The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilitiesMichele De Palma, Douglas Hanahan
Nature Cancer|June 25, 2024
Milestones in tumor vascularization and its therapeutic targetingMichele De Palma, Douglas Hanahan
Plos Genetics|September 24, 2010
Genetic deletion of the desmosomal component desmoplakin promotes tumor microinvasion in a mouse model of pancreatic neuroendocrine carcinogenesisMatthew G H Chun, Douglas Hanahan
Cancer Research|June 5, 2003
Fourteenth Annual Pezcoller Symposium: the novel dichotomy of immune interactions with tumorsDouglas Hanahan, Antonio Lanzavecchia, Enrico Mihich
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2006
Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesisHiroaki Nozawa, Christopher Chiu, Douglas Hanahan
Cancer Cell|September 29, 2015
Dual Targeting of the Autophagic Regulatory Circuitry in Gliomas with Repurposed Drugs Elicits Cell-Lethal Autophagy and Therapeutic BenefitKsenya Shchors, Aristea Massaras, Douglas Hanahan
The Journal of Clinical Investigation|September 3, 2004
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesisEnrico Giraudo, Masahiro Inoue, Douglas Hanahan
Pageof 11